Surrogacy of intermediate endpoints for overall survival in randomized controlled trials of first-line treatment for advanced soft tissue sarcoma in the pre- and post-pazopanib era: a meta-analytic evaluation

Peer review reports

Original Submission
3 Oct 2018	Submitted	Original manuscript
30 Oct 2018	Reviewed	Reviewer Report - Oleg Blyuss
1 Dec 2018	Reviewed	Reviewer Report - Carmen Guillén-Ponce
11 Dec 2018	Author responded	Author comments - Kazuhiro Tanaka
Resubmission - Version 2
11 Dec 2018	Submitted	Manuscript version 2
17 Dec 2018	Reviewed	Reviewer Report - Oleg Blyuss
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
2 Jan 2019	Editorially accepted
11 Jan 2019	Article published	10.1186/s12885-019-5268-2

Back to article page